These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
73 related items for PubMed ID: 4154540
1. Metabolism of prolintane in rats and the effect of prolintane metabolites on general activities in mice. Yoshihara S, Yoshimura H. Xenobiotica; 1974 Sep; 4(9):529-35. PubMed ID: 4154540 [No Abstract] [Full Text] [Related]
2. Metabolism of drugs. LXXVI. The metabolic fate of prolintane in rabbits. Yoshihara S, Yoshimura H. Chem Pharm Bull (Tokyo); 1972 Sep; 20(9):1906-12. PubMed ID: 4645219 [No Abstract] [Full Text] [Related]
3. Metabolism of drugs. LXXXI. Further studies on metabolism of prolintane in rabbits. Yoshihara S, Yoshimura H. Chem Pharm Bull (Tokyo); 1974 Mar; 22(3):714-7. PubMed ID: 4153635 [No Abstract] [Full Text] [Related]
4. The abuse potential of prolintane in rodents: Behavioral pharmacology approaches. Lee W, Lee JW, Kim JM, Hong YK, Kim MS, Choi SO, Kang MS. Neuropharmacology; 2022 Mar 01; 205():108917. PubMed ID: 34896117 [Abstract] [Full Text] [Related]
5. Metabolism of drugs. 78. The formation in vitro of oxoprolintane from prolintane by rabbit liver. Yoshihara S, Yoshimura H. Biochem Pharmacol; 1972 Dec 15; 21(24):3205-11. PubMed ID: 4405366 [No Abstract] [Full Text] [Related]
6. Metabolism of a pharmacologically active pyrrolidine derivative (prolintane) by lactam formation. Hucker HB, Stauffer SC, Rhodes RE. Experientia; 1972 Apr 15; 28(4):430-1. PubMed ID: 5036566 [No Abstract] [Full Text] [Related]
7. [The behavior of male albino mice in the running wheel experiment]. Kehrhahn OH. Arzneimittelforschung; 1973 Jul 15; 23(7):981-91. PubMed ID: 4147954 [No Abstract] [Full Text] [Related]
8. Behavioral effects of amfonelic acid in rats: a comparison with amphetamine and apomorphine. Jeste DV, Perlow MJ, Wyatt RJ, Stoff DM. Commun Psychopharmacol; 1979 Jul 15; 3(1):41-7. PubMed ID: 38031 [No Abstract] [Full Text] [Related]
9. Comparison of saliva and urine samples in thin-layer chromatographic detection of central nervous stimulants. Vapaatalo H, Kärkäinen S, Senius KE. Int J Clin Pharmacol Res; 1984 Jul 15; 4(1):5-8. PubMed ID: 6147318 [Abstract] [Full Text] [Related]
10. Neurochemical mechanisms in rat behavioral models of the euphorigenic and antihyperkinetic actions of psychomotor stimulant drugs. Hill RT. Psychopharmacol Bull; 1975 Jul 15; 11(3):37-8. PubMed ID: 239434 [No Abstract] [Full Text] [Related]
11. (-)Deprenyl (selegiline) is devoid of amphetamine-like behavioural effects in rats. Tímár J, Knoll B, Knoll J. Acta Physiol Hung; 1992 Jul 15; 79(2):131-7. PubMed ID: 1363925 [Abstract] [Full Text] [Related]
12. [Comparative effects of several central nervous system stimulants on confined activity in the rat]. Streichenberger G, Goguel A. Therapie; 1967 Jul 15; 22(5):991-5. PubMed ID: 4384522 [No Abstract] [Full Text] [Related]
13. Proceedings: Effect of chronic treatment with central stimulants on brain monoamines and some behavioural and physiological functions in rats, guinea pigs, and rabbits. Lewander T. Psychopharmacol Bull; 1974 Jul 15; 10(3):11-2. PubMed ID: 4153705 [No Abstract] [Full Text] [Related]
14. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats. Nakayama H, Kitaichi K, Ito Y, Hashimoto K, Takagi K, Yokoi T, Takagi K, Ozaki N, Yamamoto T, Hasegawa T. Brain Res; 2007 Dec 12; 1184():260-9. PubMed ID: 17988657 [Abstract] [Full Text] [Related]
15. Effect of morphine on locomotor activity and striatal monoamine metabolism in nicotine-withdrawn mice. Vihavainen T, Mijatovic J, Piepponen TP, Tuominen RK, Ahtee L. Behav Brain Res; 2006 Oct 02; 173(1):85-93. PubMed ID: 16846651 [Abstract] [Full Text] [Related]
16. Minaprine, but not oxiracetam, prevents desipramine-induced impairment of avoidance learning in mice. Sansone M, Battaglia M, Vetulani J. Pol J Pharmacol; 1995 Oct 02; 47(1):69-73. PubMed ID: 7550552 [Abstract] [Full Text] [Related]
17. Distribution, excretion and metabolism of prifinium bromide. Nakai T, Noguchi H, Okui M, Tada K. Arzneimittelforschung; 1970 Aug 02; 20(8):1112-9. PubMed ID: 5536514 [No Abstract] [Full Text] [Related]
18. Disposition and metabolism of 3-(3-chlorophenoxy)-N-methylpyrrolidine [14C]-carboxamide in the rat, dog, and man. Turnbull LB, Teng L, Newman J, Bruce RB, Maynard WR. Drug Metab Dispos; 1976 Aug 02; 4(4):379-86. PubMed ID: 8294 [Abstract] [Full Text] [Related]
19. The interaction of delta9-tetrahydrocannabinol and d-amphetamine in aggregated mice. Craigmill AL, Canafax DM, Curtiss FR. Res Commun Chem Pathol Pharmacol; 1974 Oct 02; 9(2):229-41. PubMed ID: 4438830 [No Abstract] [Full Text] [Related]
20. Behavioral and biochemical effects of various food-restriction regimens in the rats. Marinković P, Pesić V, Loncarević N, Smiljanić K, Kanazir S, Ruzdijić S. Physiol Behav; 2007 Oct 22; 92(3):492-9. PubMed ID: 17524433 [Abstract] [Full Text] [Related] Page: [Next] [New Search]